Example: marketing
Rencofilstat(CRV431)
Stage 1: HCC Subjects (N=16) Stage 2: HCC Subjects (N=42 total) *Administration of Rencofilstat may continue until disease progression according to RECIST version 1.1 Efficacy & Safety Analyses • Tumour measurements • Incidence rates • Safety • Tolerability Inclusion Criteria: • Failure of standard first- or
Tags:
Information
Domain:
Source:
Link to this page: